Subscribe to our insights here so you can keep on top of the latest IP developments and updates.
EPO decision T1553/22 rejects a patent on human-pig chimeras, citing ethical concerns under Article 53(a) EPC due to risks to human dignity from pluripotent stem cell use.
Daryl Penny shares insights on EPO oppositions, UPC litigation, team strategy, and career advice from 23+ years in patents. A must-read for those navigating European IP law.
The UPC's 7-year transitional period (2023–2030) allows opt-outs of “classical” European patents from UPC jurisdiction. After 2030, opt-out ends, UPC gains full control unless already opted out.
The article explores how smart packaging is revolutionizing the food and beverage industry through sustainable materials, freshness tech, interactive features, and improved tracking and security.
Boult’s partnership team has been well-represented as part of the 2025 edition of IP Stars.
Boult ranked as a tier one firm for trade mark prosecution by MIP IP stars 2025 and partner Rachel Conroy listed in the top 250 women in IP.
Once again Boult has been featured in the Sunday Times Best Places to Work.
Five partners from Boult’s team have been featured in World Intellectual Property Review (WIPR)’s Leaders 2025.
